<sup>18</sup>F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital.

Le Goubey, Jean-Baptiste; Lasnon, Charline; Nakouri, Ines; Césaire, Laure; de Pontville, Michel; Nganoa, Catherine; Kottler, Diane; Aide, Nicolas

¹⁸F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital.

Le Goubey, Jean-Baptiste; Lasnon, Charline; Nakouri, Ines; Césaire, Laure; de Pontville, Michel; Nganoa, Catherine; Kottler, Diane; Aide, Nicolas.

Afiliación

Le Goubey JB; Dermatology Department, University Hospital, 14000 Caen, France.
Lasnon C; Nuclear Medicine Department, François Baclesse Cancer Centre, 14000 Caen, France.
Nakouri I; INSERM ANTICIPE U 1086, Normandy University, 14000 Caen, France.
Césaire L; Dermatology Department, University Hospital, 14000 Caen, France.
de Pontville M; Dermatology Department, University Hospital, 14000 Caen, France.
Nganoa C; Dermatology Department, University Hospital, 14000 Caen, France.
Kottler D; Nuclear Medicine Department, University Hospital, 14000 Caen, France.
Aide N; Dermatology Department, University Hospital, 14000 Caen, France.

Diagnostics (Basel) ; 11(7)2021 Jul 01.

Article en En | MEDLINE | ID: mdl-34359281

Palabras clave

18F-FDG PET/CT; Immune checkpoint inhibitors; contrast-enhanced CT; follow-up; melanoma; metastases; therapy monitoring; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google